IMO the Chairman needs to either start delivering on the commercialisation front now, or provide more detail wrt this immediate interim period that has just commenced up until the commencement of the new CEO on 10 January 2025. In the announcement it states: "Echo IQ remains in advanced negotiations with large hospital groups, pharmaceutical companies and device manufacturers regarding the uptake of EchoSolv."
Until there is news of commercialisation actually happening there is a danger of the market losing confidence in EIQ's ability to deliver. It would be a pity if the Company sits out the next 2 months waiting for the start of the CEO.
Reassuring the market, perhaps with a Webinar, would be a good start - unless everyone's too busy securing a deal on the rollout of course.
EIQ Price at posting:
28.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)